{"id":3974,"date":"2022-11-08T15:17:00","date_gmt":"2022-11-08T15:17:00","guid":{"rendered":"https:\/\/www.impactafricasummit.org\/?page_id=3974"},"modified":"2022-11-08T15:17:00","modified_gmt":"2022-11-08T15:17:00","slug":"jullie-allen","status":"publish","type":"page","link":"https:\/\/www.impactafricasummit.org\/pias\/ias-pharma-2022-speakers\/jullie-allen\/","title":{"rendered":"Jullie Allen"},"content":{"rendered":"<div id=\"mediapat\">\n<div class=\"mdpatleft\">\n<img loading=\"lazy\" decoding=\"async\" width=\"500\" height=\"500\" src=\"https:\/\/www.impactafricasummit.org\/wp-content\/uploads\/2022\/11\/Jullie-Allen.png\" alt=\"Jullie Allen\" class=\"alignnone size-full wp-image-3975\" srcset=\"https:\/\/www.impactafricasummit.org\/pias\/wp-content\/uploads\/2022\/11\/Jullie-Allen.png 500w, https:\/\/www.impactafricasummit.org\/pias\/wp-content\/uploads\/2022\/11\/Jullie-Allen-300x300.png 300w, https:\/\/www.impactafricasummit.org\/pias\/wp-content\/uploads\/2022\/11\/Jullie-Allen-150x150.png 150w, https:\/\/www.impactafricasummit.org\/pias\/wp-content\/uploads\/2022\/11\/Jullie-Allen-200x200.png 200w, https:\/\/www.impactafricasummit.org\/pias\/wp-content\/uploads\/2022\/11\/Jullie-Allen-100x100.png 100w\" sizes=\"auto, (max-width: 500px) 100vw, 500px\" \/>\n<\/div>\n<div class=\"mdpatright\">\n<h2>Jullie Allen<\/h2>\n<p class=\"mdpat\">Head Of Development Operations,<br \/>\nGlobal Blood Therapeutics (PFIZER)<\/p>\n<p>Julie is the Head of Development Operations at GBT (as of 5th October part of Pfizer). In this capacity Julie has oversight of GBT\u2019s  SCD clinical trials,  with the intent of creating a world where patients, families, and communities  living with SCD, live well and prosper.  Seeking opportunities to better understand the local experience and leveraging those insights to shape the operational aspects of trial execution to achieve the optimal patient and site experience as well as create long lasting relationships.  <\/p>\n<\/div>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>Jullie Allen Head Of Development Operations, Global Blood Therapeutics (PFIZER) Julie is the Head of Development Operations at GBT (as of 5th October part of Pfizer). In this capacity Julie has oversight of GBT\u2019s SCD clinical trials, with the intent of creating a world where patients, families, and communities living with SCD, live well and [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":2531,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":""},"class_list":["post-3974","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/www.impactafricasummit.org\/pias\/wp-json\/wp\/v2\/pages\/3974","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.impactafricasummit.org\/pias\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.impactafricasummit.org\/pias\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.impactafricasummit.org\/pias\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.impactafricasummit.org\/pias\/wp-json\/wp\/v2\/comments?post=3974"}],"version-history":[{"count":1,"href":"https:\/\/www.impactafricasummit.org\/pias\/wp-json\/wp\/v2\/pages\/3974\/revisions"}],"predecessor-version":[{"id":3976,"href":"https:\/\/www.impactafricasummit.org\/pias\/wp-json\/wp\/v2\/pages\/3974\/revisions\/3976"}],"up":[{"embeddable":true,"href":"https:\/\/www.impactafricasummit.org\/pias\/wp-json\/wp\/v2\/pages\/2531"}],"wp:attachment":[{"href":"https:\/\/www.impactafricasummit.org\/pias\/wp-json\/wp\/v2\/media?parent=3974"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}